MedPage Today on MSN
Study questions methods used in Alzheimer's drug analysis
Quantile aggregation may lead to overstated claims about amyloid-cognition relationships ...
FRAMINGHAM, Mass., April 07, 2026--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of investigational therapies and diagnostic assays for ...
NEW YORK, April 2, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing innovative treatments for unmet medical needs, today announced ...
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from ...
ALZ-NET is the first network developed specifically for new FDA-approved Alzheimer's treatments, collecting real-world evidence on drug effectiveness and side effects over a long period of time. The ...
Add Yahoo as a preferred source to see more of our stories on Google. June is Alzheimer’s & Brain Awareness Month, and the Alzheimer’s Association is encouraging individuals and families across the ...
Partnering with our friends from The Rotary Club of Lake Conroe, we hosted our first Alzheimer’s and Dementia Awareness Week ...
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results